Habib Arslan, Anjum Khalid Mahmood, Iqbal Riffat, Jaffar Ghulam, Ashraf Zeeshan, Khalid Malik ShahZaib, Taj Muhammad Usman, Zainab Syeda Wafa, Umair Muhammad, Zohaib Muhammad, Khalid Tabinda
Laboratory of Molecular Immunology, State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, PR China.
Iran J Immunol. 2023 Mar 14;20(1):1-15. doi: 10.22034/iji.2023.94097.2284.
The most effective method to minimize the prevalence of infectious diseases is vaccination. Vaccines enhance immunity and provide protection against different kinds of infections. Subunit vaccines are safe and less toxic, but due to their lower immunogenicity, they need adjuvants to boost the immune system. Adjuvants are small particles/molecules integrated into a vaccine to enhance the immunogenic feedback of antigens. They play a significant role to enhance the potency and efficiency of vaccines. There are several types of adjuvants with different mechanisms of action; therefore, improved knowledge of their immunogenicity will help develop a new generation of adjuvants. Many trials have been designed using different kinds of vaccine adjuvants to examine their safety and efficacy, but in practice, only a few have entered in animal and human clinical trials. However, for the development of safe and effective vaccines, it is important to have adequate knowledge of the side effects and toxicity of different adjuvants. The current review discussed the adjuvants which are available for producing modern vaccines as well as some new classes of adjuvants in clinical trials.
将传染病患病率降至最低的最有效方法是接种疫苗。疫苗可增强免疫力并提供针对不同类型感染的保护。亚单位疫苗安全且毒性较小,但由于其免疫原性较低,它们需要佐剂来增强免疫系统。佐剂是整合到疫苗中的小颗粒/分子,以增强抗原的免疫原性反馈。它们在增强疫苗的效力和效率方面发挥着重要作用。有几种类型的佐剂,其作用机制不同;因此,深入了解它们的免疫原性将有助于开发新一代佐剂。已经设计了许多使用不同种类疫苗佐剂的试验来检验其安全性和有效性,但在实践中,只有少数进入了动物和人体临床试验。然而,为了开发安全有效的疫苗,充分了解不同佐剂的副作用和毒性很重要。本综述讨论了可用于生产现代疫苗的佐剂以及一些处于临床试验阶段的新型佐剂。